--- title: "Pre-market trend | China Traditional Chinese Medicine (0570.HK) slightly warmed up on May 7, is there a hint of spring for the TCM concept?" type: "News" locale: "en" url: "https://longbridge.com/en/news/285513523.md" description: "Yesterday's closing price for China Traditional Chinese Medicine rose slightly by 1.19%, with a trading volume of approximately HKD 92 million, which is a slight increase compared to usual, reflecting the market's attention to its mid-term development prospects. The MACD daily line has not yet formed a clear strong bullish signal, but the latest dynamics in the electronic chemical pharmaceutical sector provide good visibility for it. Under the influence of news, the government's support for the traditional Chinese medicine industry is evident. With the continuous expansion of domestic healthcare demand and the increasing awareness of healthy living, the demand potential in the traditional Chinese medicine market is gradually being released. The company is further enhancing its market competitiveness through continuous research and development, innovation initiatives, and the expansion of its market network. Technically, the stock price trend remains stable above the mid-line trend level, reflecting that short-term positions are still primarily focused on position management. As market sentiment gradually recovers, if downward resistance diminishes, we can expect more significant liquidity changes and a positive drive for the market to refocus on the traditional Chinese medicine concept. The short-term trend is positively referenced, especially with the support of favorable industry prospects, traditional Chinese medicine concept stocks are not afraid of short-term market fluctuations. Caution is needed regarding the impact of the board's substantive decisions on stock prices, as well as the potential chain reaction from important economic indicators exceeding expectations. This article provides only technical analysis and market information for reference and does not constitute any investment advice. The market carries uncertainties, and investors should make independent decisions based on their own circumstances" datetime: "2026-05-08T01:00:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285513523.md) - [en](https://longbridge.com/en/news/285513523.md) - [zh-HK](https://longbridge.com/zh-HK/news/285513523.md) --- # Pre-market trend | China Traditional Chinese Medicine (0570.HK) slightly warmed up on May 7, is there a hint of spring for the TCM concept? Yesterday, China Traditional Chinese Medicine's stock price rose slightly by 1.19%, with a trading volume of approximately HKD 92 million, which is a slight increase compared to usual, reflecting the market's attention to its mid-term development prospects. The MACD daily line has not yet formed a clear strong bullish signal, but the latest dynamics in the electronic chemical pharmaceutical sector provide good visibility. Under the backdrop of news hedging, the national support for the traditional Chinese medicine industry policy is evident. With the continuous expansion of domestic healthcare demand and the increasing awareness of healthy living, the demand potential in the traditional Chinese medicine market is gradually being released. The company is further enhancing its market competitiveness through continuous research and development, innovation initiatives, and the expansion of its market network. From a technical perspective, the stock price trend remains stable above the mid-line trend level, reflecting that short-term positions are still primarily focused on position management. As market sentiment gradually improves, if downward resistance diminishes, we can expect more significant liquidity changes and a positive drive for the market to refocus on the traditional Chinese medicine concept. The short-term trend is positively referenced, especially with the support of favorable industry prospects, traditional Chinese medicine concept stocks are not afraid of short-term market fluctuations. Caution is needed regarding the impact of the board's substantive decisions on stock prices, as well as the potential chain reaction caused by important economic indicators exceeding expectations. _This article only provides technical analysis and market information for reference and does not constitute any investment advice. The market carries uncertainties, and investors should make independent decisions based on their own circumstances._ ### Related Stocks - [00570.HK](https://longbridge.com/en/quote/00570.HK.md) - [516930.CN](https://longbridge.com/en/quote/516930.CN.md) - [588130.CN](https://longbridge.com/en/quote/588130.CN.md) - [513120.CN](https://longbridge.com/en/quote/513120.CN.md) - [159929.CN](https://longbridge.com/en/quote/159929.CN.md) - [159992.CN](https://longbridge.com/en/quote/159992.CN.md) - [512010.CN](https://longbridge.com/en/quote/512010.CN.md) - [159938.CN](https://longbridge.com/en/quote/159938.CN.md) - [513700.CN](https://longbridge.com/en/quote/513700.CN.md) - [510660.CN](https://longbridge.com/en/quote/510660.CN.md) - [512290.CN](https://longbridge.com/en/quote/512290.CN.md) - [513060.CN](https://longbridge.com/en/quote/513060.CN.md) - [513200.CN](https://longbridge.com/en/quote/513200.CN.md) - [02841.HK](https://longbridge.com/en/quote/02841.HK.md) - [159316.CN](https://longbridge.com/en/quote/159316.CN.md) - [520880.CN](https://longbridge.com/en/quote/520880.CN.md) - [520690.CN](https://longbridge.com/en/quote/520690.CN.md) - [516610.CN](https://longbridge.com/en/quote/516610.CN.md) - [589720.CN](https://longbridge.com/en/quote/589720.CN.md) - [159506.CN](https://longbridge.com/en/quote/159506.CN.md) ## Related News & Research - [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md) - [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md) - [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md) - [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md) - [Wuxi AppTec to Raise Around $1 Billion Through Zero Coupon Convertible Bonds](https://longbridge.com/en/news/286487023.md)